160 likes | 632 Views
2. A. Contract research organizations. Offer pharmaceutical companies a range of services covering all phases of drug developmentIncreasing emphasis on informatics services to complement other activitiesEnable big pharma firms to staff for valleys rather than peaks of research cycleFacilitate worldwide testing of new productsDependence on pharmaceutical companies' budgets creates high volatility in resultsCROs' involvement in genetic research will have a long-term payback.
E N D